Nexavar , Sorafenib / Bulk

Hazard statements (CLP)

H360Df, H362, H372

Code

Statements

H360Df

May damage the unborn child; Suspected of damaging fertility

SECTION 2: Hazards identification

(29 CFR 1910.1200) Emergency Overview Colour various Form solid, tablet, powder Odour odourless Product poses little or no hazard if spilled and no unusual hazard if involved in a fire. See Potential Health Effects if the recommended dosage is exceeded. Appropriate route of entry: Ingestion Accidental: Inhalation Skin contact Eye contact GHS Classification Reproductive toxicity Category 1B Specific target organ toxicity - repeated exposure (Oral) Category 1 Effects on or via lactation GHS Label element

Signal word

Danger

Hazard statements

H360Df May damage the unborn child. Suspected of damaging fertility. H362 May cause harm to breast-fed children. H372 Causes damage to organs through prolonged or repeated exposure if swallowed.

Prevention

P260 Do not breathe dust or mist. P281 Use personal protective equipment as required. P262 Do not get in eyes, on skin, or on clothing. P263 Avoid contact during pregnancy/ while nursing.

Response

P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Other hazards which do not result in classification

None known.

Medical Conditions Generally Aggravated by Exposure

Use only as directed., See product packaging and the Exposure Physicians' Desk Reference (PDR) for further information concerning adverse effects and drug interaction precautions., This is a pharmaceutical material.

2.1 Classification of the substance or mixture

Reproductive toxicity : Category 1B Specific target organ : Category 1 toxicity - repeated exposure (Oral) Effects on or via lactation